Status:
RECRUITING
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Me...
Detailed Description
Until recently, contemporary approaches to cancer care have failed to consistently tailor communication approaches to patients with low health literacy. They have produced mixed results in regard to i...
Eligibility Criteria
Inclusion
- All patients on oral chemotherapeutic agents
- Clinical diagnosis of stage IV breast cancer
- Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrent radiation therapy)
- Clinical diagnosis of stage IV non-small cell lung cancer
- Clinical diagnosis of stage IV renal cell carcinoma
- Clinical diagnosis of stage IV ovarian carcinoma
- Clinical diagnosis of multiple myeloma
- Clinical diagnosis of chronic myelogenous leukemia on TKI
- Clinical diagnosis of myelodysplastic syndrome on Lenalidomide
- Adjuvant treatment for Gastro Intestinal Stromal Tumor
- Clinical diagnosis of chronic Lymphocytic Leukemia
- Clinical diagnosis of metastatic Prostate cancer
- Clinical diagnosis of hepatocellular Carcinoma
- Clinical diagnosis of stage IV Melanoma
- Clinical diagnosis of myelofibrosis/myeloproliferative neoplasms
- Age \>18 years
- ECOG Performance Status \<3
Exclusion
- ECOG Performance Status of 3 and above
- Concurrent chemo radiation
- Non-English speaker
- Clinical diagnosis of dementia, or otherwise unable to give informed consent.
- History of non-compliance (defined as the history of 2 or more missed appointments in the clinic).
- Pregnant patients
- Nursing Home Patients
- Incarcerated
Key Trial Info
Start Date :
July 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03245411
Start Date
July 20 2017
End Date
December 20 2025
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert Einstein Healthcare Network
Philadelphia, Pennsylvania, United States, 19141